Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Human Gene Therapy
1.2 Key Market Segments
1.2.1 Human Gene Therapy Segment by Type
1.2.2 Human Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Human Gene Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Human Gene Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Human Gene Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Human Gene Therapy Market Competitive Landscape
3.1 Global Human Gene Therapy Sales by Manufacturers (2019-2024)
3.2 Global Human Gene Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Human Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Gene Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Human Gene Therapy Sales Sites, Area Served, Product Type
3.6 Human Gene Therapy Market Competitive Situation and Trends
3.6.1 Human Gene Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Gene Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Human Gene Therapy Industry Chain Analysis
4.1 Human Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Human Gene Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Human Gene Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Gene Therapy Sales Market Share by Type (2019-2024)
6.3 Global Human Gene Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Human Gene Therapy Price by Type (2019-2024)
7 Human Gene Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Gene Therapy Market Sales by Application (2019-2024)
7.3 Global Human Gene Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Human Gene Therapy Sales Growth Rate by Application (2019-2024)
8 Human Gene Therapy Market Segmentation by Region
8.1 Global Human Gene Therapy Sales by Region
8.1.1 Global Human Gene Therapy Sales by Region
8.1.2 Global Human Gene Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Human Gene Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Gene Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Gene Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Gene Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Gene Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Biogen
9.1.1 Biogen Human Gene Therapy Basic Information
9.1.2 Biogen Human Gene Therapy Product Overview
9.1.3 Biogen Human Gene Therapy Product Market Performance
9.1.4 Biogen Business Overview
9.1.5 Biogen Human Gene Therapy SWOT Analysis
9.1.6 Biogen Recent Developments
9.2 Sarepta Therapeutics
9.2.1 Sarepta Therapeutics Human Gene Therapy Basic Information
9.2.2 Sarepta Therapeutics Human Gene Therapy Product Overview
9.2.3 Sarepta Therapeutics Human Gene Therapy Product Market Performance
9.2.4 Sarepta Therapeutics Business Overview
9.2.5 Sarepta Therapeutics Human Gene Therapy SWOT Analysis
9.2.6 Sarepta Therapeutics Recent Developments
9.3 Gilead Sciences
9.3.1 Gilead Sciences Human Gene Therapy Basic Information
9.3.2 Gilead Sciences Human Gene Therapy Product Overview
9.3.3 Gilead Sciences Human Gene Therapy Product Market Performance
9.3.4 Gilead Sciences Human Gene Therapy SWOT Analysis
9.3.5 Gilead Sciences Business Overview
9.3.6 Gilead Sciences Recent Developments
9.4 Amgen
9.4.1 Amgen Human Gene Therapy Basic Information
9.4.2 Amgen Human Gene Therapy Product Overview
9.4.3 Amgen Human Gene Therapy Product Market Performance
9.4.4 Amgen Business Overview
9.4.5 Amgen Recent Developments
9.5 Novartis
9.5.1 Novartis Human Gene Therapy Basic Information
9.5.2 Novartis Human Gene Therapy Product Overview
9.5.3 Novartis Human Gene Therapy Product Market Performance
9.5.4 Novartis Business Overview
9.5.5 Novartis Recent Developments
9.6 Orchard Therapeutics
9.6.1 Orchard Therapeutics Human Gene Therapy Basic Information
9.6.2 Orchard Therapeutics Human Gene Therapy Product Overview
9.6.3 Orchard Therapeutics Human Gene Therapy Product Market Performance
9.6.4 Orchard Therapeutics Business Overview
9.6.5 Orchard Therapeutics Recent Developments
9.7 Spark Therapeutics
9.7.1 Spark Therapeutics Human Gene Therapy Basic Information
9.7.2 Spark Therapeutics Human Gene Therapy Product Overview
9.7.3 Spark Therapeutics Human Gene Therapy Product Market Performance
9.7.4 Spark Therapeutics Business Overview
9.7.5 Spark Therapeutics Recent Developments
9.8 Agc Biologics
9.8.1 Agc Biologics Human Gene Therapy Basic Information
9.8.2 Agc Biologics Human Gene Therapy Product Overview
9.8.3 Agc Biologics Human Gene Therapy Product Market Performance
9.8.4 Agc Biologics Business Overview
9.8.5 Agc Biologics Recent Developments
9.9 Anges
9.9.1 Anges Human Gene Therapy Basic Information
9.9.2 Anges Human Gene Therapy Product Overview
9.9.3 Anges Human Gene Therapy Product Market Performance
9.9.4 Anges Business Overview
9.9.5 Anges Recent Developments
9.10 Bluebird Bio
9.10.1 Bluebird Bio Human Gene Therapy Basic Information
9.10.2 Bluebird Bio Human Gene Therapy Product Overview
9.10.3 Bluebird Bio Human Gene Therapy Product Market Performance
9.10.4 Bluebird Bio Business Overview
9.10.5 Bluebird Bio Recent Developments
9.11 Jazz Pharmaceuticals
9.11.1 Jazz Pharmaceuticals Human Gene Therapy Basic Information
9.11.2 Jazz Pharmaceuticals Human Gene Therapy Product Overview
9.11.3 Jazz Pharmaceuticals Human Gene Therapy Product Market Performance
9.11.4 Jazz Pharmaceuticals Business Overview
9.11.5 Jazz Pharmaceuticals Recent Developments
9.12 Dynavax Technologies
9.12.1 Dynavax Technologies Human Gene Therapy Basic Information
9.12.2 Dynavax Technologies Human Gene Therapy Product Overview
9.12.3 Dynavax Technologies Human Gene Therapy Product Market Performance
9.12.4 Dynavax Technologies Business Overview
9.12.5 Dynavax Technologies Recent Developments
9.13 Human Stem Cells Institute
9.13.1 Human Stem Cells Institute Human Gene Therapy Basic Information
9.13.2 Human Stem Cells Institute Human Gene Therapy Product Overview
9.13.3 Human Stem Cells Institute Human Gene Therapy Product Market Performance
9.13.4 Human Stem Cells Institute Business Overview
9.13.5 Human Stem Cells Institute Recent Developments
9.14 Sibiono Genetech
9.14.1 Sibiono Genetech Human Gene Therapy Basic Information
9.14.2 Sibiono Genetech Human Gene Therapy Product Overview
9.14.3 Sibiono Genetech Human Gene Therapy Product Market Performance
9.14.4 Sibiono Genetech Business Overview
9.14.5 Sibiono Genetech Recent Developments
9.15 Shanghai Sunway Biotech
9.15.1 Shanghai Sunway Biotech Human Gene Therapy Basic Information
9.15.2 Shanghai Sunway Biotech Human Gene Therapy Product Overview
9.15.3 Shanghai Sunway Biotech Human Gene Therapy Product Market Performance
9.15.4 Shanghai Sunway Biotech Business Overview
9.15.5 Shanghai Sunway Biotech Recent Developments
9.16 Uniqure N.V.
9.16.1 Uniqure N.V. Human Gene Therapy Basic Information
9.16.2 Uniqure N.V. Human Gene Therapy Product Overview
9.16.3 Uniqure N.V. Human Gene Therapy Product Market Performance
9.16.4 Uniqure N.V. Business Overview
9.16.5 Uniqure N.V. Recent Developments
9.17 Gensight Biologics S.A.
9.17.1 Gensight Biologics S.A. Human Gene Therapy Basic Information
9.17.2 Gensight Biologics S.A. Human Gene Therapy Product Overview
9.17.3 Gensight Biologics S.A. Human Gene Therapy Product Market Performance
9.17.4 Gensight Biologics S.A. Business Overview
9.17.5 Gensight Biologics S.A. Recent Developments
9.18 Celgene Corporation
9.18.1 Celgene Corporation Human Gene Therapy Basic Information
9.18.2 Celgene Corporation Human Gene Therapy Product Overview
9.18.3 Celgene Corporation Human Gene Therapy Product Market Performance
9.18.4 Celgene Corporation Business Overview
9.18.5 Celgene Corporation Recent Developments
9.19 Cellectis
9.19.1 Cellectis Human Gene Therapy Basic Information
9.19.2 Cellectis Human Gene Therapy Product Overview
9.19.3 Cellectis Human Gene Therapy Product Market Performance
9.19.4 Cellectis Business Overview
9.19.5 Cellectis Recent Developments
9.20 Sangamo Therapeutics
9.20.1 Sangamo Therapeutics Human Gene Therapy Basic Information
9.20.2 Sangamo Therapeutics Human Gene Therapy Product Overview
9.20.3 Sangamo Therapeutics Human Gene Therapy Product Market Performance
9.20.4 Sangamo Therapeutics Business Overview
9.20.5 Sangamo Therapeutics Recent Developments
9.21 Mustang Bio
9.21.1 Mustang Bio Human Gene Therapy Basic Information
9.21.2 Mustang Bio Human Gene Therapy Product Overview
9.21.3 Mustang Bio Human Gene Therapy Product Market Performance
9.21.4 Mustang Bio Business Overview
9.21.5 Mustang Bio Recent Developments
9.22 AGTC
9.22.1 AGTC Human Gene Therapy Basic Information
9.22.2 AGTC Human Gene Therapy Product Overview
9.22.3 AGTC Human Gene Therapy Product Market Performance
9.22.4 AGTC Business Overview
9.22.5 AGTC Recent Developments
9.23 Poseida Therapeutics
9.23.1 Poseida Therapeutics Human Gene Therapy Basic Information
9.23.2 Poseida Therapeutics Human Gene Therapy Product Overview
9.23.3 Poseida Therapeutics Human Gene Therapy Product Market Performance
9.23.4 Poseida Therapeutics Business Overview
9.23.5 Poseida Therapeutics Recent Developments
10 Human Gene Therapy Market Forecast by Region
10.1 Global Human Gene Therapy Market Size Forecast
10.2 Global Human Gene Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Human Gene Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Human Gene Therapy Market Size Forecast by Region
10.2.4 South America Human Gene Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Human Gene Therapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Human Gene Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Human Gene Therapy by Type (2025-2030)
11.1.2 Global Human Gene Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Human Gene Therapy by Type (2025-2030)
11.2 Global Human Gene Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Human Gene Therapy Sales (Kilotons) Forecast by Application
11.2.2 Global Human Gene Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
